About the Company
Zoetis Inc. (/zō-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index.
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ZTS News
Zoetis (ZTS) Stock Declines Amid Concerns Over Arthritis Drugs Impacting Pets - Hagens Berman
April 24, 2024) - Hagens Berman, a prominent national trial law firm, is urging investors who suffered substantial losses in Zoetis Inc. (NYSE: ZTS) to promptly report their losses here. Additionally, ...
Zoetis (ZTS) Fell After Reporting Mixed Fourth Quarter Results
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A ...
ROSEN, LEADING INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Zoetis Inc. (NYSE: ZTS) resulting from allegations that Zoetis ...
Zoetis’s stock falls 8% after report that its arthritis shots may have sickened pets
Zoetis Inc.’s stock ZTS, -8.44% tumbled 7% Friday to lead S&P 500 decliners, after a Wall Street Journal report that the ...
Despite Lawsuit Risks: Why Zoetis Remains A Compelling Investment
Despite the setbacks, Zoetis' core business remains strong, with robust top-line and bottom-line growth expectations. Read ...
Animal Health Giant Zoetis Stock Crumbles: Possible Side Effect Of Its Pet Arthritis Pain Drugs Sickened Dogs, Cats
Zoetis Inc (NYSE:ZTS) tumbled to a 52-week low after a media report suggested the company’s arthritis shots, Librela and ...
Zoetis Stock Falls After Journal Reports Scrutiny of Its Arthritis Drugs for Pets
Shares of Zoetis fell Friday after the Journal reported that the company's arthritis drugs for dogs and cats have come under ...
Zoetis Inc. (ZTS)
PARSIPPANY, N.J., April 01, 2024--Zoetis Inc. (NYSE: ZTS) today announced the appointment of Gavin D.K. Hattersley, President, Chief Executive Officer and Director of Molson Coors Beverage Company ...
Zoetis Sinks Most in 17 Months After Arthritis Drugs Report (1)
Zoetis Inc. tumbled on Friday after a news report detailed safety concerns associated with the use of the pharmaceutical company’s arthritis drugs for animals.
Zoetis Inc's Dividend Analysis
Zoetis Inc (NYSE:ZTS) recently announced a dividend of $0.43 per share, payable on 2024-06-04, with the ex-dividend date set ...
Zoetis Inc Class A ZTS
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Loading the latest forecasts...